Clinical Trial Evidence: What UK Studies Reveal About Results
What Is Better Mounjaro or Wegovy: Understanding UK Clinical Evidence
When evaluating what is better Mounjaro or Wegovy for weight loss results in the UK, the clinical evidence reveals distinct mechanisms and outcomes for each prescription-only medicine. Wegovy (semaglutide) demonstrated ~15% average weight loss at 68 weeks in the landmark STEP 1 trial, with patients receiving the medication alongside a reduced-calorie diet and increased physical activity. Mounjaro (tirzepatide) operates through a dual GIP and GLP-1 receptor mechanism, whilst Wegovy targets GLP-1 receptors exclusively.
Both treatments require dose escalation protocols and clinical supervision through our GPhC #9012878 registered pharmacy. The question of what is better Mounjaro or Wegovy ultimately depends on individual patient factors, tolerability profiles, and prescriber clinical judgement. UK patients can access both medications through EverydayMeds following a comprehensive clinical assessment that evaluates BMI, comorbidities, and treatment history to determine the most appropriate therapeutic approach.
Wegovy Pricing and Value: UK Treatment Costs Breakdown
Understanding the investment required for Wegovy treatment helps inform decisions about what is better Mounjaro or Wegovy from a cost perspective. Our single pen prices start from £79.99 for the 0.25mg starter dose, progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers benefit from our FIRST40 discount code applied at checkout, whilst returning patients use DOSE25 for continued savings.
Our convenience bundles provide multi-month supply options, including the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 covering your first three months of dose escalation. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without monthly reordering. When comparing what is better Mounjaro or Wegovy financially, both treatments represent significant investments in long-term weight management, with bundle options providing supply security and reduced ordering frequency.
STEP Trial Results: What Clinical Evidence Shows About Wegovy
The STEP clinical trial programme provides robust evidence for Wegovy's efficacy in UK-approved weight management protocols. STEP 1 demonstrated ~15% average weight loss at 68 weeks compared to ~2.4% with placebo, whilst STEP 3 achieved ~16% weight reduction when combined with intensive behavioural therapy. STEP 5 confirmed sustained results of ~clinically studied weight loss maintained at two years, addressing long-term effectiveness concerns.
The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, expanding Wegovy's clinical benefits beyond weight management alone. When evaluating what is better Mounjaro or Wegovy based on published evidence, both treatments have demonstrated significant efficacy in their respective clinical programmes, though direct head-to-head comparisons remain limited due to different trial designs and patient populations studied.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone that regulates appetite and food intake. The medication works on brain appetite centres, particularly in the hypothalamus, to reduce hunger signals and promote feelings of fullness after consuming smaller meal portions. This mechanism helps patients achieve sustainable calorie reduction without the intense hunger typically associated with conventional dieting approaches. Wegovy also slows gastric emptying, extending satiety duration and reducing between-meal cravings that often derail weight management efforts. The once-weekly injection schedule using the FlexTouch pen device provides consistent therapeutic levels throughout the seven-day dosing interval, supporting adherence to the treatment regimen. Unlike appetite suppressants that work through stimulant mechanisms, Wegovy's GLP-1 approach addresses the underlying hormonal signals that regulate energy balance and food consumption patterns.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined process begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, BMI calculation, and weight management goals. Our qualified prescribers review each application within 3 working days (express 24-hour service available), ensuring clinical appropriateness and safety screening before approval. Once prescribed, Wegovy is dispensed from our GPhC #9012878 registered pharmacy using temperature-controlled cold-chain packaging to maintain medication stability during transit. Next-day delivery is standard for approved prescriptions, with discrete packaging and detailed administration instructions included with every order. Our clinical team remains available for ongoing support throughout your treatment journey, addressing questions about dose escalation, side effect management, and optimal injection techniques to maximise treatment effectiveness.
Storage and Practical Considerations: UK Usage Guidelines
Wegovy requires refrigerated storage at 2-8°C before first use, but offers a significant practical advantage with 6 weeks room temperature stability below 30°C once removed from the fridge. This storage flexibility exceeds Mounjaro's 21-day room temperature limit, providing greater convenience for UK patients who travel frequently or prefer flexible dosing schedules. The FlexTouch pen design eliminates the need for online pharmacy mixing or complex preparation, with pre-filled pens ready for immediate subcutaneous injection. Dose escalation follows a mandatory schedule starting at 0.25mg weekly for four weeks, progressing through 0.5mg, 1mg, 1.7mg, before reaching the 2.4mg maintenance dose at week 17. Each pen contains four weekly doses, with clear dose indicators and safety mechanisms to prevent accidental overdosing. Proper injection site rotation between abdomen, thigh, and upper arm areas helps minimise local irritation and ensures consistent medication absorption throughout treatment.
Mounjaro vs Wegovy: UK Patient Considerations and Clinical Profiles
When UK patients ask what is better Mounjaro or Wegovy, the answer depends on individual clinical profiles and treatment response patterns. Wegovy's established STEP trial data provides extensive evidence for cardiovascular risk reduction alongside weight management, making it particularly suitable for patients with existing heart disease risk factors. The medication's 6-week room temperature storage advantage benefits frequent travellers and those with unpredictable schedules requiring dosing flexibility.
Mounjaro's dual GIP and GLP-1 mechanism offers a different therapeutic approach, though both medications require similar dose escalation protocols and dietary modifications for optimal results. Patient tolerance profiles vary significantly, with some individuals responding better to single-pathway GLP-1 activation while others benefit from dual-receptor targeting. Both treatments are available through EverydayMeds with identical clinical assessment and prescriber review processes, ensuring patients receive the most appropriate medication based on comprehensive medical evaluation rather than marketing preferences.
Start Your Weight Management Journey: Expert Clinical Support Available
Beginning treatment with either Wegovy or Mounjaro through EverydayMeds ensures access to ongoing clinical support throughout your weight management journey. New customers can apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 for continued savings on single pens and convenience bundles. Our clinical team provides injection training, side effect guidance, and dose escalation monitoring to optimise treatment outcomes and minimise adverse effects. The question of what is better Mounjaro or Wegovy becomes clearer through individual treatment response, which our prescribers monitor through regular clinical reviews and adjustment recommendations. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which prescription-only medicine aligns with your weight management goals and medical profile. Both treatments represent evidence-based approaches to sustainable weight loss when combined with appropriate dietary and lifestyle modifications under professional medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
